Moderna price target drops, fintech Outperform, FDA hits tobacco

In This Article:

Yahoo Finance's Brad Smith reviews Wednesday's trending stocks on Wealth.

Moderna's (MRNA) price target slashed to $38 from $70 by Morgan Stanley (MS), implying an 11% potential upside based on its last closing price. Analysts cite lowered 2025 revenue outlook and vaccine market competition.

Fintech leaders SoFi (SOFI) and Affirm (AFRM) have been initiated by William Blair in research coverage, and are currently both rated Outperform.

Tobacco stocks, such as British American Tobacco (BTI), Imperial Brands (IMBBY), and Philip Morris (PM), are under pressure after US Food and Drug Administration (FDA) announces a proposal to cap nicotine levels in cigarettes.

To watch more expert insights and analysis on the latest market action, check out more Wealth here.

This post was written by Josh Lynch